Methylation profiling

Dataset Information

0

Relevance of temozolomide for elderly patients with MGMT promoter-methylated malignant astrocytomas outside the RTK I methylation group [HD collective]

ABSTRACT: The data contains Illumina 450k/EPIC array methylation files from 380 glioblastoma patients of the Heidelberg Neuro-Oncology Center

ORGANISM(S): Homo sapiens

PROVIDER: GSE122994 | GEO | 2019/10/31

REPOSITORIES: GEO

Json Xml

Similar Datasets

Methylation profiling Relevance of temozolomide for elderly patients with MGMT promoter-methylated malignant astrocytomas outside the RTK I methylation group
2019-10-31 | GSE122920 | GEO
Genomics Relevance of temozolomide for elderly patients with MGMT promoter-methylated malignant astrocytomas outside the RTK I methylation group [HD collective]
| PRJNA507175 | ENA
Genomics Relevance of temozolomide for elderly patients with MGMT promoter-methylated malignant astrocytomas outside the RTK I methylation group
| PRJNA506921 | ENA
Unknown Superiority of temozolomide over radiotherapy for elderly patients with RTK II methylation class, MGMT promoter methylated malignant astrocytoma.
| S-EPMC7594575 | biostudies-literature
Unknown Malignant astrocytomas of elderly patients lack favorable molecular markers: an analysis of the NOA-08 study collective.
| S-EPMC3714152 | biostudies-literature
Unknown MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas and MGMT Silencing to Temozolomide Sensitivity in IDH-Mutant Gliomas.
| S-EPMC6048353 | biostudies-literature
Unknown Temozolomide Sensitizes MGMT-Deficient Tumor Cells to ATR Inhibitors.
| S-EPMC6810597 | biostudies-literature
Unknown P01.013 Long-term analyses of the NOA-08 randomized phase III trial of temozolomide versus radiotherapy for elderly patients with malignant astrocytomas
| S-EPMC6144530 | biostudies-literature
Unknown Temozolomide: The evidence for its therapeutic efficacy in malignant astrocytomas.
| S-EPMC2899776 | biostudies-other
Unknown Bortezomib administered prior to temozolomide depletes MGMT, chemosensitizes glioblastoma with unmethylated MGMT promoter and prolongs animal survival.
| S-EPMC6888814 | biostudies-literature